Abbvie Inc Stock Market Value

ABBV Stock  USD 180.52  0.17  0.09%   
AbbVie's market value is the price at which a share of AbbVie trades on a public exchange. It measures the collective expectations of AbbVie Inc investors about its performance. AbbVie is selling for under 180.52 as of the 28th of March 2024; that is 0.09 percent increase since the beginning of the trading day. The stock's lowest day price was 180.52.
With this module, you can estimate the performance of a buy and hold strategy of AbbVie Inc and determine expected loss or profit from investing in AbbVie over a given investment horizon. Check out AbbVie Correlation, AbbVie Volatility and AbbVie Alpha and Beta module to complement your research on AbbVie.
Symbol

AbbVie Inc Price To Book Ratio

Is AbbVie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.67)
Dividend Share
5.99
Earnings Share
2.72
Revenue Per Share
30.723
Quarterly Revenue Growth
(0.05)
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AbbVie 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AbbVie's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AbbVie.
0.00
02/27/2024
No Change 0.00  0.0 
In 30 days
03/28/2024
0.00
If you would invest  0.00  in AbbVie on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding AbbVie Inc or generate 0.0% return on investment in AbbVie over 30 days. AbbVie is related to or competes with Agilent Technologies, and Mediwound. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide More

AbbVie Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AbbVie's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AbbVie Inc upside and downside potential and time the market with a certain degree of confidence.

AbbVie Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for AbbVie's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AbbVie's standard deviation. In reality, there are many statistical measures that can use AbbVie historical prices to predict the future AbbVie's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AbbVie's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
179.43180.35181.27
Details
Intrinsic
Valuation
LowRealHigh
162.32205.14206.06
Details
Naive
Forecast
LowNextHigh
179.87180.79181.71
Details
29 Analysts
Consensus
LowTargetHigh
145.79160.21177.83
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AbbVie. Your research has to be compared to or analyzed against AbbVie's peers to derive any actionable benefits. When done correctly, AbbVie's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AbbVie Inc.

AbbVie Inc Backtested Returns

AbbVie appears to be very steady, given 3 months investment horizon. AbbVie Inc secures Sharpe Ratio (or Efficiency) of 0.29, which signifies that the company had a 0.29% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for AbbVie Inc, which you can use to evaluate the volatility of the firm. Please makes use of AbbVie's mean deviation of 0.6922, and Risk Adjusted Performance of 0.1702 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, AbbVie holds a performance score of 22. The firm shows a Beta (market volatility) of 0.32, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, AbbVie's returns are expected to increase less than the market. However, during the bear market, the loss of holding AbbVie is expected to be smaller as well. Please check AbbVie's coefficient of variation, semi variance, relative strength index, as well as the relationship between the treynor ratio and rate of daily change , to make a quick decision on whether AbbVie's price patterns will revert.

Auto-correlation

    
  -0.02  

Very weak reverse predictability

AbbVie Inc has very weak reverse predictability. Overlapping area represents the amount of predictability between AbbVie time series from 27th of February 2024 to 13th of March 2024 and 13th of March 2024 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AbbVie Inc price movement. The serial correlation of -0.02 indicates that only 2.0% of current AbbVie price fluctuation can be explain by its past prices.
Correlation Coefficient-0.02
Spearman Rank Test0.03
Residual Average0.0
Price Variance1.83

AbbVie Inc lagged returns against current returns

Autocorrelation, which is AbbVie stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AbbVie's stock expected returns. We can calculate the autocorrelation of AbbVie returns to help us make a trade decision. For example, suppose you find that AbbVie has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

AbbVie regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AbbVie stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AbbVie stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AbbVie stock over time.
   Current vs Lagged Prices   
       Timeline  

AbbVie Lagged Returns

When evaluating AbbVie's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AbbVie stock have on its future price. AbbVie autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AbbVie autocorrelation shows the relationship between AbbVie stock current value and its past values and can show if there is a momentum factor associated with investing in AbbVie Inc.
   Regressed Prices   
       Timeline  

Pair Trading with AbbVie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbbVie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will appreciate offsetting losses from the drop in the long position's value.

Moving together with AbbVie Stock

  0.89EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against AbbVie Stock

  0.9MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.9VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.82KA Kineta Inc Report 29th of March 2024 PairCorr
  0.81CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.8DBVT DBV Technologies Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to AbbVie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbbVie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbbVie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbbVie Inc to buy it.
The correlation of AbbVie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbbVie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbbVie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbbVie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out AbbVie Correlation, AbbVie Volatility and AbbVie Alpha and Beta module to complement your research on AbbVie.
Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AbbVie technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of AbbVie technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of AbbVie trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...